Cambridge Healthtech Institute’s 6th Annual

Disease Modeling  

Developing, Validating, Scaling, and Automating Physiologically Relevant Disease Models

June 2-4, 2020

 

Inadequate representation of the human tissue environment during a preclinical screen can result in inaccurate predictions of a drug candidate’s effects. Thus, investigators are searching for preclinical models that closely resemble original tissue for predicting clinical outcome. With advances in reprogramming and differentiation technologies, as well as with the recent availability of gene editing approaches, we are finally able to create more complex and phenotypically accurate models that span all therapeutic areas. At Cambridge Healthtech Institute's 6th Annual Disease Modeling conference, we will discuss the next generation of models as well as strategies to overcome common bottlenecks such as standardization, scaling and work flow integration.

Who Should Attend: cell biologists, tissue engineers, assay developers, screening managers and drug developers

Coverage will include, but is not limited to:

3D Cellular and in vivo Modeling

  • Development of high-throughput screening (HTS) for “oids” (tumoroids, spheroids, organoids) in a cost-effective manner across different therapeutic areas
  • Co-culturing successes
  • Merging in vitro, in vivo and in silico methods
  • Imaging techniques
  • Animal models (mouse, zebrafish, etc.)
  • Predictable cancer IO models for improved translation

 

Stem Cell-Based Models

  • Establishing induced pluripotent stem cell (iPSC) models to provide a predictive assessment of drug-induced toxicity
  •  Case studies on patient-derived hiPSC for preclinical drug assessment
  • Industry-academia collaboration in the field of translational iPS cell research
  • Patient-on-a-chip system
  • Infrastructure/automation for drug discovery
  • Synthetic and defined extracellular matrices for advanced cellular models
  • Genome editing to generate advanced and phenotypically accurate human cellular disease models

 

Bioengineered Models

  • Case studies on development and validation on bioengineering techniques such as (but not limited to) organs-on-a-chip and bioprinting
  • Clinical trial-on-a-chip
  • Creating more complex microenvironments
  • Incorporating smart biomaterial matrices to provide monitoring tools

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is November 22, 2019.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Mana Chandhok

Conference Producer

Cambridge Healthtech Institute

Phone: 781-972-1350
Email: mchandhok@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Rod Eymael
Manager, Business Development
Phone: 781-247-6286
Email: reymael@healthtech.com

 

Companies L-Z
Joseph Vacca, M.S.
Director, Business Development
Phone: 781-972-5431
Email: jvacca@healthtech.com